Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET (original) (raw)

Nature volume 385, pages 634–636 (1997)Cite this article

Abstract

Schizophrenia is believed to involve altered activation of dopamine receptors, and support for this hypothesis conies from the antipsychotic effect of antagonists of the dopamine D2 receptor (D2R)1. D2R is expressed most highly in the striatum, but most of the recent positron emission tomography (PET) studies have failed to show any change in D2R densities in the striatum of schizophrenics2–5, raising the possibility that other receptors may also be involved. In particular, the dopamine D1 receptor (D1R), which is highly expressed in the prefrontal cortex6, has been implicated in the control of working memory7,8, and working memory dysfunction is a prominent feature of schizophrenia9. We have therefore used PET to examine the distribution of D1R and D2R in brains of drug-naive or drug-free schizophrenic patients. Although no differences were observed in the striatum relative to control subjects, binding of radioligand to D1R was reduced in the prefrontal cortex of schizophrenics. This reduction was related to the severity of the negative symptoms (for instance, emotional withdrawal) and to poor performance in the Wisconsin Card Sorting Test10. We propose that dysfunction of D1R signalling in the prefrontal cortex may contribute to the negative symptoms and cognitive deficits seen in schizophrenia.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Seeman, P., Lee, T., Chau-Wong, M. & Wong, K. Nature 261, 717–719 (1976).
    Article ADS CAS Google Scholar
  2. Hietala, J. et al. Archs Gen. Psychiat. 51, 116–123 (1994).
    Article CAS Google Scholar
  3. Martinot, J. L., Person-Magnan, P., Huret, J. D. & Mazoyer, B. Am. J. Psychiat. 147, 44–50 (1990).
    Article CAS Google Scholar
  4. Nordström, A. L., Farde, L., Eriksson, L. & Halldin, C. Psychiat. Res. Neuroimag. 61, 67–83 (1995).
    Article Google Scholar
  5. Farde, L. et al. Archs Gen. Psychiat. 47, 213–219 (1990).
    Article CAS Google Scholar
  6. Hall, H. et al. Neuropsychopharmacology 11, 245–256 (1994).
    Article CAS Google Scholar
  7. Sawaguchi, T. & Goldman-Rakic, P. S. Science 251, 947–950 (1991).
    Article ADS CAS Google Scholar
  8. Williams, G. V. & Goldman-Rakic, P. S. Nature 376, 572–575 (1995).
    Article ADS CAS Google Scholar
  9. Goldman-Rakic, P. S. J. Neuropsychiat. Clin. Neurosci. 6, 348–357 (1994).
    Article CAS Google Scholar
  10. Kashima. H. Jpn J. Psychopharmacol. 11, 83–88 (1991).
    CAS Google Scholar
  11. Farde, L., Halldin, C., Stone, E. S. & Sedvall, G. Psychopharmacology 92, 278–284 (1987).
    Article CAS Google Scholar
  12. Anderson, P. & Gronvald, F. Life Sci. 38, 1507–1514 (1986).
    Article Google Scholar
  13. Wong, D. F. et al. Science 226, 1393–1396 (1984).
    Article ADS CAS Google Scholar
  14. Hess, E. J., Bracha, H. S., Kleinman, J. E. & Creese, I. Life Sci. 40, 1487–1497 (1987).
    Article CAS Google Scholar
  15. Sedvall, G. & Farde, L. Lancet 346, 743–749 (1995).
    Article CAS Google Scholar
  16. Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F. & Welch, M. J. Ann. Neural. 15, 217–227 (1984).
    Article CAS Google Scholar
  17. Weinberger, D. R., Berman, K. F. & Zec, R. F. Archs Gen. Psychiat. 43, 114–124 (1986).
    Article CAS Google Scholar
  18. Brozoski, T., Brown, R., Rosvold, H. & Goldman-Rakic, P. S. Science 205, 929–931 (1979).
    Article ADS CAS Google Scholar
  19. Davidson, M. & Davis, K. Archs Gen Psychiat. 45, 561–563 (1988).
    Article CAS Google Scholar
  20. Daniel, D., Weinberger, D. & Jones, D. J. Neurosci. 11, 1907–1917 (1991).
    Article CAS Google Scholar
  21. Dolan, R. J. et al. Nature 378, 180–182 (1995).
    Article ADS CAS Google Scholar
  22. Asahina, M. et al. Acta Neurol. Scand. 91, 437–443 (1995).
    Article CAS Google Scholar
  23. Suhara, T. et al. Psychopharmacology 103, 41–45 (1991).
    Article CAS Google Scholar
  24. Patlak, C. & Blasberg, R. J. Cereb. Blood Flow Metab. 5, 584–590 (1985).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Neuropsychiatry, Tokyo Medical and Dental University School of Medicine, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113, Japan
    Yoshiro Okubo, Omi Terasaki, Yasuhiro Someya, Takeshi Sassa, Eisuke Matsushima & Michio Toru
  2. Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage-ku, Chiba, 263, Japan
    Yoshiro Okubo, Tetsuya Suhara, Kazutoshi Suzuki, Kaoru Kobayashi, Osamu Inoue, Omi Terasaki, Yasuhiro Someya, Takeshi Sassa, Yasuhiko Sudo, Masaomi Iyo & Yukio Tateno

Authors

  1. Yoshiro Okubo
    You can also search for this author inPubMed Google Scholar
  2. Tetsuya Suhara
    You can also search for this author inPubMed Google Scholar
  3. Kazutoshi Suzuki
    You can also search for this author inPubMed Google Scholar
  4. Kaoru Kobayashi
    You can also search for this author inPubMed Google Scholar
  5. Osamu Inoue
    You can also search for this author inPubMed Google Scholar
  6. Omi Terasaki
    You can also search for this author inPubMed Google Scholar
  7. Yasuhiro Someya
    You can also search for this author inPubMed Google Scholar
  8. Takeshi Sassa
    You can also search for this author inPubMed Google Scholar
  9. Yasuhiko Sudo
    You can also search for this author inPubMed Google Scholar
  10. Eisuke Matsushima
    You can also search for this author inPubMed Google Scholar
  11. Masaomi Iyo
    You can also search for this author inPubMed Google Scholar
  12. Yukio Tateno
    You can also search for this author inPubMed Google Scholar
  13. Michio Toru
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Okubo, Y., Suhara, T., Suzuki, K. et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.Nature 385, 634–636 (1997). https://doi.org/10.1038/385634a0

Download citation

This article is cited by